VectorB2B is a member of the EATRIS network

In May 2022, VectorB2B joined the EATRIS network in the ATMP, Small Molecules and Vaccines platforms.

EATRIS is the European infrastructure for translational medicine. EATRIS brings together resources and services for research communities to translate scientific discoveries into benefits for patients. EATRIS is what is known as an ‘ERIC’, which is a non-profit European Research Infrastructure Consortium. This specific legal form is designed to facilitate the joint establishment and operation of research infrastructures of European interest.

‘EATRIS’ has been the acronym of the European Advanced Translational Research Infrastructure in Medicine since the formation of the organization in 2007. In November 2013, EATRIS became the first biomedical science infrastructure to receive European Research Infrastructure Consortium status, established by the European Commission.

EATRIS provides access to a vast array of pre-clinical and clinical expertise and facilities that are available within 144+ top-tier academic centers across Europe. EATRIS focus on improving and optimizing preclinical and early clinical development of drugs, vaccines and diagnostics.  Solutions are developed in the fields of advanced therapy medicinal products, imaging and tracing, small molecules, vaccines and biomarkers. 

About Eatris

More News

VectorB2B will exhibit at BIOSPAIN 2023 on 26-28 Sept in Barcelona

BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 34% of delegates came from outside of Spain. This year, BIOSPAIN goes back to Barcelona, the main biotech cluster in Spain and one of […]

VectorB2B will exhibit at the European Drug Discovery Innovation Congress on 12-13 Sept in Barcelona

This event has a reputation for providing outstanding networking experiences with industry experts, thought leaders and fellow attendees to explore the latest trends, innovations, and challenges in the drug discovery landscape. Meet us at VectorB2B booth Link for the conference:

VectorB2B is part of the Bio-Hub consortium aiming for the development of new biopharmaceuticals in Portugal targeting international markets

VectorB2B is one of the co-promoters of the Bio-Hub Agenda – a National R&D Platform for…

© 2024 digital connection | All rights reserved | Privacy policy| Data Privacy Contact Form